Dan Sherbenou, MD, PhD

Associate Professor

Sherbenou, Dan, MD, PhD
I have devoted my professional life to understanding what makes cells become cancerous and how to turn that knowledge into the best possible treatments. I seek to empower my patients with knowledge about their disease and its treatments. For me, it is a privilege to provide cancer care and I strive to help patients realize their best possible quality of life. 


Sherbenou Lab Members

Kady Dennis

PhD Student, Cancer Biology Program

For her research, Kady focuses on the myeloma initiating cells present in minimal residual disease (MRD) after successful therapy such as CAR-T cells. She aims to understand how these residual cells escape treatment and lead to eventual disease relapse.

Kady comes to us from Penn State University where she received a B.S. in Biochemistry and Molecular Biology. Her undergraduate thesis work examined the mechanism of action of the chemotherapeutic CX-5461. She also worked on a meta-analysis of clinical trials during COVID aimed at re-purposing already approved therapeutics.

Kady spends her free time in Colorado watching movies, reading, baking, exploring the city, and playing with her dog.

Kady Dennis

Image of Alana Keller

Alana Hoey

PhD Student, Cancer Biology Program

Alana’s research focuses on immunotherapies for multiple myeloma including bispecific and trispecific T-cell engagers. She began her undergraduate career at the University of West Georgia before transferring to the University of North Carolina Chapel Hill to graduate with a B.S. in Chemistry. During undergrad, Alana studied triple negative breast cancer at UNC-Chapel Hill and pulmonary fibrosis during her time as an AMGEN Scholar at the National Institutes of Health. Before joining the Sherbenou Lab, she worked as a laboratory technician at the UNC HIV Cure Center after undergrad.

In her free time, Alana loves long-distance running, baking, and spending time with friends.

Sarah Parzych

Research Services Professional (I)

Sarah received her BA from the University of Connecticut (Go Huskies!), where she studied biology and chemistry. In the lab, Sarah's focus is on the nuclear export inhibitor selinexor and its resistance mechanisms. She also works with novel anti-myeloma CAR-T cells that are developed in-house here at CU Anschutz.

Picture of Sarah

Picture of Zach Walker

Zachary Walker, MB (ASCP)

Laboratory Manager

Zach’s current research is on the development of a new therapeutic drug class for multiple myeloma patients targeting protein translation. Zach is also our lab manager and his technical expertise spans the variety of techniques we use, including multiparameter flow cytometry and in vivo models of myeloma. Prior to coming to the University of Colorado, Zach worked at Northwestern University’s Center for Innovation in Global Health Technologies in Chicago, where he helped develop molecular point-of-care diagnostics for HIV and TB. He received a master’s degree in biology from Northern Arizona University in Flagstaff, for which he focused on the characterization of bacterial and fungal soil communities.

CU Hematology Logo

Where next?

Contact us smile grey  150x125

Hematology (SOM)

CU Anschutz

Research Complex II

12700 East 19th Avenue

Mail Stop B170

Aurora, CO 80045

Appointments: 720-848-6400

CMS Login